The present invention relates to a novel family of protein kinase inhibitors more specifically the present invention is directed to inhibitors of the members of the Tec or Src protein kinase families. The present invention also relates to processes for the preparation of these compounds to the pharmaceutical composition comprising them and to their use in the treatment of proliferative inflammatory infectious or autoimmune diseases disorder or condition in which protein kinase activity is implicated. More particularly the present invention relates to a compound of Formula I.
